These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 4710038)

  • 1. Demonstration of cell-mediated and blocking immune responses to tumor antigens in cancer patients with the colony-inhibition-in-gel test.
    Cummings FJ; Heppner GH; Stolbach L; Calabresi P
    Isr J Med Sci; 1973 Mar; 9(3):308-16. PubMed ID: 4710038
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell-mediated immunity in prostatic cancer.
    Ablin RJ; Bhatti RA; Nagubadi S; Zamora S; Guinan PD
    Clin Oncol; 1980 Sep; 6(3):253-64. PubMed ID: 7428203
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell-mediated and humoral immune reactions to human tumours.
    Baldwin RW; Embleton MJ; Jones JS; Langman MJ
    Int J Cancer; 1973 Jul; 12(1):73-83. PubMed ID: 4790710
    [No Abstract]   [Full Text] [Related]  

  • 4. Problems in the clinical use of the microcytotoxicity assay for measuring cell-mediated immunity to tumor cells.
    Heppner G; Henry E; Stolbach L; Cummings F; McDonough E; Calabresi P
    Cancer Res; 1975 Aug; 35(8):1931-7. PubMed ID: 1149017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on specificity of cell-mediated immunity to human tumors.
    Takasugi M; Mickey MR; Terasaki PI
    J Natl Cancer Inst; 1974 Dec; 53(6):1527-38. PubMed ID: 4140237
    [No Abstract]   [Full Text] [Related]  

  • 6. Experiences with leukocyte adherence inhibition in human cancer.
    Maluish AE
    Cancer Res; 1979 Feb; 39(2 Pt 2):644-8. PubMed ID: 367590
    [No Abstract]   [Full Text] [Related]  

  • 7. Demonstration of an antigen common to several varieties of neoplasia.
    Lo Gerfo P; Krupey J; Hansen HJ
    N Engl J Med; 1971 Jul; 285(3):138-41. PubMed ID: 5104234
    [No Abstract]   [Full Text] [Related]  

  • 8. Leukocyte adherence inhibition. The detection of cellular responsiveness and serum 'blocking' factors in malignancy.
    Ablin RJ
    Allergol Immunopathol (Madr); 1975; 3(5):357-66. PubMed ID: 1227281
    [No Abstract]   [Full Text] [Related]  

  • 9. [Carcinoembryonic antigen in oncology].
    Tkacheva GA
    Med Radiol (Mosk); 1983 Aug; 28(8):69-76. PubMed ID: 6310310
    [No Abstract]   [Full Text] [Related]  

  • 10. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
    Halliday WJ; Koppi TA; Khan JM; Davis NC
    J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific antibody activation of lymphocytes for cell-mediated cytotoxicity against cultured target cells.
    Takasugi M; Kinoshita K
    J Natl Cancer Inst; 1974 Dec; 53(6):1539-44. PubMed ID: 4474407
    [No Abstract]   [Full Text] [Related]  

  • 12. [Problems of tumor immunity and the possibility of immunotherapy in tumor].
    Shimoyama M
    Nihon Rinsho; 1971; 29(6):1515-29. PubMed ID: 4933610
    [No Abstract]   [Full Text] [Related]  

  • 13. The in vitro migration inhibition of mononuclear cells in patients with colorectal carcinoma.
    Kowalczyk D; Zembala M; Popiela T; Labza H
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):435-9. PubMed ID: 749793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasms.
    Hellström I; Sjögren HO; Warner G; Hellström KE
    Int J Cancer; 1971 Mar; 7(2):226-37. PubMed ID: 5104167
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibody responses to herpesviruses (EBV, HSV and CMV) in cancer patients given cultured lymphoblastoid cells.
    Minowada J; Moore GE; Gerner RE; Matheisz JS
    Clin Exp Immunol; 1972 May; 11(1):43-50. PubMed ID: 4338950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro studies of autologous and allogeneic recognition in patients with gastric and colorectal adenocarcinoma].
    Machado I; Cabrera L; Anderson C; Meilijson O; Pérez L; Bianco N
    G E N; 1985; 39(1):1-19. PubMed ID: 2939005
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemolytic processes in human carcinoma.
    Adelsberger L
    Proc Rudolf Virchow Med Soc City N Y; 1968-1969; 27():224-34. PubMed ID: 5292175
    [No Abstract]   [Full Text] [Related]  

  • 18. Cell-mediated immunity and specific serum factors in human cancer: the leukocyte adherence inhibition test.
    Maluish A; Halliday WJ
    J Natl Cancer Inst; 1974 May; 52(5):1415-20. PubMed ID: 4831432
    [No Abstract]   [Full Text] [Related]  

  • 19. Growth-inhibition effect of lymph-node cells from cancer patients on autochthonous tumor cell.
    Orita K; Kobayashi M; Konaga E; Kolumai Y; Hiramatsu M
    Acta Med Okayama; 1973 Dec; 27(5):133-40. PubMed ID: 4273582
    [No Abstract]   [Full Text] [Related]  

  • 20. Lymphocyte sensitivity and cellular immunity in neoplasia.
    Faguet GB; Balcerzak SP; Lobuglio AF
    Biomedicine; 1973 Feb; 19(2):43-7. PubMed ID: 4731978
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.